Mirum Pharmaceuticals Inc (MIRM)
44.73
+1.25
(+2.87%)
USD |
NASDAQ |
Nov 22, 16:00
44.73
0.00 (0.00%)
Pre-Market: 20:00
Mirum Pharmaceuticals Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.159M |
September 30, 2023 | -202.36M |
June 30, 2023 | 0.00 |
March 31, 2023 | -14.48M |
December 31, 2022 | 0.28M |
September 30, 2022 | -86.36M |
June 30, 2022 | -3.905M |
March 31, 2022 | -17.38M |
December 31, 2021 | 0.00 |
Date | Value |
---|---|
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -6.914M |
December 31, 2020 | -84.92M |
September 30, 2020 | -2.271M |
June 30, 2020 | -0.025M |
March 31, 2020 | -44.66M |
December 31, 2019 | 0.00 |
September 30, 2019 | -67.20M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-202.36M
Minimum
Sep 2023
0.28M
Maximum
Dec 2022
-23.14M
Average
-0.0125M
Median
Stock Buybacks (Quarterly) Benchmarks
Arcutis Biotherapeutics Inc | 0.00 |
Cytokinetics Inc | 0.00 |
Amicus Therapeutics Inc | -19.15M |
MannKind Corp | 0.00 |
TG Therapeutics Inc | 2.149M |